Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Review Articles

Treatment of Dupuytren's Disease

Collagenase Clostridium histolyticum

Gocke, Thomas V. III DMSc, ATC, PA-C, DFAAPA1,2

Author Information
JBJS Journal of Orthopaedics for Physician Assistants: April-June 2020 - Volume 8 - Issue 2 - p e0024
doi: 10.2106/JBJS.JOPA.19.00024



publishes corrections when they are of significance to patient care, scientific data or record-keeping, or authorship, whether that error was made by an author, editor, or staff. Errata also appear in the online version and are attached to files downloaded from .

In the article entitled “Treatment of Dupuytren's Disease: Collagenase Clostridium histolyticum” (JBJS JOPA 2020; 8[2]: e0024), by Thomas V. Gocke III, in the “Adverse Effects Associated with CCH Injections” section, the citation of reference 28 following the quote “immune system acts as antigen-presenting cells and collect the collagenase and transport it through the lymph system via the axillary lymph nodes where anti-AUX I and anti AUX II antibodies are produced. This process may cause a local inflammatory response along the lymph vessels” is incorrect. The correct reference number is 36, Sanjuan-Cervero et al.

JBJS Journal of Orthopaedics for Physician Assistants. 8(2):e0024ER, April-June 2020.

Copyright © 2020 by The Journal of Bone and Joint Surgery, Incorporated.